219 related articles for article (PubMed ID: 15470221)
1. Prevention of hepatocellular carcinoma.
Wands JR
N Engl J Med; 2004 Oct; 351(15):1567-70. PubMed ID: 15470221
[No Abstract] [Full Text] [Related]
2. Hepatitis B virus infection--natural history and clinical consequences.
Ganem D; Prince AM
N Engl J Med; 2004 Mar; 350(11):1118-29. PubMed ID: 15014185
[No Abstract] [Full Text] [Related]
3. Lamivudine for patients with chronic hepatitis B and advanced liver disease.
Liaw YF; Sung JJ; Chow WC; Farrell G; Lee CZ; Yuen H; Tanwandee T; Tao QM; Shue K; Keene ON; Dixon JS; Gray DF; Sabbat J;
N Engl J Med; 2004 Oct; 351(15):1521-31. PubMed ID: 15470215
[TBL] [Abstract][Full Text] [Related]
4. Risk assessment for the development of hepatocellular carcinoma: according to on-treatment viral response during long-term lamivudine therapy in hepatitis B virus-related liver disease.
Eun JR; Lee HJ; Kim TN; Lee KS
J Hepatol; 2010 Jul; 53(1):118-25. PubMed ID: 20471129
[TBL] [Abstract][Full Text] [Related]
5. [Modern strategy in the treatment of chronic hepatitis B: progress and prospects].
Isakov VA
Eksp Klin Gastroenterol; 2007; (2):107-12. PubMed ID: 17539354
[No Abstract] [Full Text] [Related]
6. Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma.
Liaw YF
Semin Liver Dis; 2005; 25 Suppl 1():40-7. PubMed ID: 16103980
[TBL] [Abstract][Full Text] [Related]
7. Prevention of hepatocellular carcinoma: the holy grail of hepatitis B treatment.
Sherman M
J Hepatol; 2009 May; 50(5):854-6. PubMed ID: 19303162
[No Abstract] [Full Text] [Related]
8. [Prevention for the development of hepatitis B virus-related hepatocellular carcinoma by anti-viral treatment].
Ebinuma H; Saito H
Nihon Rinsho; 2011 May; 69 Suppl 4():540-5. PubMed ID: 22096977
[No Abstract] [Full Text] [Related]
9. [Chronic hepatitis B].
Thimme R; Spangenberg HC; Blum HE
Dtsch Med Wochenschr; 2008 Jan; 133(4):135-8. PubMed ID: 18197589
[No Abstract] [Full Text] [Related]
10. Treatment of chronic hepatitis B infection.
Omata M
N Engl J Med; 1998 Jul; 339(2):114-5. PubMed ID: 9654543
[No Abstract] [Full Text] [Related]
11. Chemoprevention of hepatocellular carcinoma in chronic hepatitis B with lamivudine?
Lim LY; Kowdley KV
Gastroenterology; 2005 Dec; 129(6):2120-2; discussion 2122. PubMed ID: 16344085
[No Abstract] [Full Text] [Related]
12. Recent progress and new trends in the treatment of hepatitis B.
Alberti A; Brunetto MR; Colombo M; Craxì A
J Med Virol; 2002 Jul; 67(3):458-62. PubMed ID: 12116046
[TBL] [Abstract][Full Text] [Related]
13. Can antiviral therapy for chronic hepatitis B enhance the progression to hepatocellular carcinoma?
Warner N; Locarnini S
Antivir Ther; 2009; 14(2):139-42. PubMed ID: 19430088
[No Abstract] [Full Text] [Related]
14. Emerging therapies of hepatitis B and C.
Chen RY; Desmond PV; Locarnini SA
J Gastroenterol Hepatol; 2002 Dec; 17 Suppl():S471-81. PubMed ID: 12534781
[No Abstract] [Full Text] [Related]
15. Events occurring at the time of breakthrough hepatitis during lamivudine treatment for chronic hepatitis B.
Yokosuka O
J Gastroenterol; 2004 Aug; 39(8):813-4. PubMed ID: 15338383
[No Abstract] [Full Text] [Related]
16. Does treatment with interferon-based therapy improve the natural history of chronic hepatitis B infection?
Lau GK
J Hepatol; 2007 Jan; 46(1):6-8. PubMed ID: 17112628
[No Abstract] [Full Text] [Related]
17. End points of therapy in chronic hepatitis B.
Ahmed SN; Ecochard M; Zoulim F
Expert Rev Gastroenterol Hepatol; 2010 Feb; 4(1):37-49. PubMed ID: 20136588
[TBL] [Abstract][Full Text] [Related]
18. A 3-year clinical trial of lamivudine in treatment of patients with chronic hepatitis B.
Yao GB; Cui ZY; Wang BE; Yao JL; Zeng MD
Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):188-93. PubMed ID: 15138107
[TBL] [Abstract][Full Text] [Related]
19. Chronic hepatitis B, biological basis for new therapeutic strategies.
Dianzani F
J Biol Regul Homeost Agents; 1999; 13(2):71-9. PubMed ID: 10503729
[No Abstract] [Full Text] [Related]
20. [Lamivudine treatment consensus from relative experts in 2003].
Lamivudine Clinical Practice Group
Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):497-9. PubMed ID: 12939188
[No Abstract] [Full Text] [Related]
[Next] [New Search]
